Patient treatment needs in atopic dermatitis: A real‐world cohort study
Journal of the European Academy of Dermatology and Venereology · 30.07.2026
DOI: 10.1111/jdv.70648 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 30.07.2026. Verfasst von Kristina Ludemann und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Atopic dermatitis (AD) substantially affects quality of life, yet standardized severity measures may not capture patient‐centred priorities, making systematic needs assessment essential for personalized care.
Objectives
This study aimed to systematically assess and rank treatment needs in adults with moderate to severe AD, identify patient subgroups with distinct need profiles and evaluate how well these needs were met after 2 years of specialized dermatological care.
Methods
In this prospective observational study from the TREATgermany registry, 697 adults with moderate to severe AD completed the validated Patient Benefit Index (PBI) at baseline (T1) and at 2‐year follow‐up (T2), capturing treatment goal importance and achievement. Subgroup analyses were performed based on age, sex, educational status and age at AD onset. Associations between clinical measures and perceived benefit were analysed.
Results
The most frequently prioritized treatment goals were being free of itching (97.8% high agreement), regaining control of the disease (95.3%) and relief from skin burning (92.0%). The importance of itch reduction was not correlated with baseline pruritus intensity, and perceived benefit was more closely linked to relative clinical improvement than to absolute disease severity. Beyond these shared priorities, treatment needs varied across subgroups: older patients valued treatment safety and reduced dependence on medical care, women emphasized psychosocial and appearance‐related goals, individuals with lower educational status highlighted financial concerns and patients with adult‐onset AD prioritized diagnostic certainty and disease control. After 2 years, 96.6% of patients reported meaningful treatment benefit. Patient‐reported outcomes (POEM) were more strongly associated with perceived benefit than physician‐assessed measures (oSCORAD, EASI).
Conclusion
Patient treatment needs in AD vary by demographic and clinical factors, with pruritus consistently rated as the highest priority. Patient‐reported outcomes align more closely with perceived benefit than physician assessments, underscoring the value of systematic needs assessments to guide individualized treatment decisions and shared decision‐making.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.
- Center for Evidence-Based Healthcare, University Hospital Carl Gustav Carus and Carl Gustav Carus Faculty of Medicine, Technische Universitaet Dresden, Dresden, Germany.
- Center for Inflammatory Skin Diseases, Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
- Institute for Health Services Research in Dermatology Hamburg, University Medical Center Hamburg Eppendorf, Hamburg, Germany.
- Practice Dr. Med. Thomas Schaefer and Dr. Med. Doreen Belz, Cologne, Germany.
- Practice Dr. Med. Anne Bong, Emmerich, Germany.
ORCID-Profile: Kristina Ludemann, Stephan Traidl, Annice Heratizadeh, Tatjana Honstein, Barbara Kind, Luise Heinrich, Inken Harder, Dora Stölzl, Matthias Augustin, Susanne Abraham, Andreas Pinter, Sven Quist, Caroline Mann, Michael Sticherling, Knut Schaekel, Kathrin Meinhardt, Stephan Weidinger, Jochen Schmitt, Thomas Werfel
Zitieren
APA
Ludemann, K., Traidl, S., Cornelius, A., Naim, J., Heratizadeh, A., Honstein, T., Kind, B., Heinrich, L., Harder, I., Stölzl, D., Augustin, M., Schaefer, T., Bong, A., Abraham, S., Pinter, A., Ramaker-Brunke, J., Schulz-Kiesow, M., Quist, S., Schwarz, B., …, & TREATgermany study group (2026). Patient treatment needs in atopic dermatitis: A real‐world cohort study. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.70648
Vancouver
Ludemann K, Traidl S, Cornelius A, Naim J, Heratizadeh A, Honstein T, et al. Patient treatment needs in atopic dermatitis: A real‐world cohort study. Journal of the European Academy of Dermatology and Venereology. 2026. doi:10.1111/jdv.70648
BibTeX
@article{Ludemann2026,
author = {Ludemann, Kristina and Traidl, Stephan and Cornelius, Angela and Naim, Joëlle and Heratizadeh, Annice and Honstein, Tatjana and Kind, Barbara and Heinrich, Luise and Harder, Inken and Stölzl, Dora and Augustin, Matthias and Schaefer, Thomas and Bong, Anne and Abraham, Susanne and Pinter, Andreas and Ramaker-Brunke, Jutta and Schulz-Kiesow, Michael and Quist, Sven and Schwarz, Beate and Biedermann, Tilo and Asefi, Mohammad and Mann, Caroline and Adler, Nicole and Sticherling, Michael and Schaekel, Knut and Herrmann, Anke and Meinhardt, Kathrin and Stahl, Maren and Handrick, Christiane and Anders, Sabine and Weidinger, Stephan and Schmitt, Jochen and Werfel, Thomas and TREATgermany study group, TREATgermany study group},
title = {Patient treatment needs in atopic dermatitis: A real‐world cohort study},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2026},
doi = {10.1111/jdv.70648}
}
EUVIMED